Abstract: A laser radar device includes: a light source for outputting laser light; a scanner for causing the laser light to scan; a first optical system for receiving the laser light caused to scan by the scanner and incident on the first optical system and emitting the incident laser light in such a manner that a horizontal component of the incident laser light is different from a horizontal component of the laser light to be emitted; and a second optical system for receiving the laser light caused to scan by the scanner and incident on the second optical system and emitting the incident laser light in such a manner that an incident area of the incident laser light in the horizontal direction is the same as an incident area of the first optical system in the horizontal direction, and an emission area of the incident laser light is different from an emission area of the first optical system.

Abstract: An optical transmission unit (3) transmits an optical signal having a light intensity set as a Low level component of a pulse. An optical partial reflector (6) is provided on a path through which transmission light is transmitted from a circulator (5) to the atmosphere, and reflects the optical signal. A detection unit (11) performs coherent detection on reception light using, as local light, a signal in a Low level section in the optical signal reflected by the optical partial reflector (6).

Abstract: A wind speed prediction device includes processing circuitry configured to acquire a scattering signal that is each of a plurality of beams after being emitted to space and scattered in the space; variably set a range bin width as distance resolution of each of the acquired scattering signals in accordance with an elevation angle of each of the beams emitted to the space, and calculate at least one Doppler frequency of at least one range bin corresponding to a two-dimensional plane including an observation region from the each of the scattering signals; estimate at least one wind speed distribution in the two-dimensional plane from the plurality of Doppler frequencies calculated; and predict a wind speed in the observation region from the at least one wind speed distribution in the two-dimensional plane using a two-dimensional Navier-Stokes equation.

Abstract: The present invention relates to a pharmaceutical composition comprising a P2X3 and/or P2X2/3 receptor antagonist for the treatment of neuropathic pain, nociceptive pain or visceral pain, as well as interstitial cystitis and/or bladder pain syndrome. It is a pharmaceutical composition for treating and/or preventing neuropathic pain, nociceptive pain, or visceral pain, as well as interstitial cystitis and/or bladder pain syndrome, comprising a compound represented by Formula (I): or a pharmaceutically acceptable salt thereof.

Abstract: The present invention provides a novel P2X3 and/or P2X2/3 receptor antagonist. A compound represented by the formula (I): wherein Ra, Rb and Rc are, (a) Ra and Rb are taken together ?Z; and Rc is a group represented by R1c; or (b) Rb and Rc are taken together to form a bond; and Ra is a group represented by —Y—R1a; R1a and R1c are each independently hydrogen, substituted or unsubstituted alkyl, etc.; R2 and R3 are each independently substituted or unsubstituted aryl, etc.; R4a and R4b are each independently hydrogen, substituted or unsubstituted alkyl, etc.; X is —N(R5)—, etc.; R5 is hydrogen, substituted or unsubstituted lower alkyl, etc.; —Y— is —O—, etc.; ?Z is ?O, etc.; and n is an integer of 0 to 4.

Abstract: The present invention provides a novel P2X3 and/or P2X2/3 receptor antagonist. A compound represented by the formula (I): wherein Ra, Rb and Rc are, (a) Ra and Rb are taken together ?Z; and Rc is a group represented by R1c; or (b) Rb and Rc are taken together to form a bond; and Ra is a group represented by —Y—R1a; R1a and R1c are each independently hydrogen, substituted or unsubstituted alkyl, etc.; R2 and R3 are each independently substituted or unsubstituted aryl, etc.; R4a and R4b are each independently hydrogen, substituted or unsubstituted alkyl, etc.; X is —N(R5)—, etc.; R5 is hydrogen, substituted or unsubstituted lower alkyl, etc.; —Y— is —O—, etc.; ?Z is ?O, etc.; and n is an integer of 0 to 4.

Abstract: The present invention provides a novel P2X3 and/or P2X2/3 receptor antagonist. A compound represented by the formula (I): wherein Ra, Rb and Rc are, (a) Ra and Rb are taken together ?Z; and Rc is a group represented by R1c; or (b) Rb and Rc are taken together to form a bond; and Ra is a group represented by —Y—R1a; R1a and R1c are each independently hydrogen, substituted or unsubstituted alkyl, etc.; R2 and R3 are each independently substituted or unsubstituted aryl, etc.; R4a and R4b are each independently hydrogen, substituted or unsubstituted alkyl, etc.; X is —N(R5)—, etc.; R5 is hydrogen, substituted or unsubstituted lower alkyl, etc.; —Y— is —O—, etc.; ?Z is ?O, etc.; and n is an integer of 0 to 4.

Abstract: The present invention provides a compound represented by the formula (I): wherein R1, R2, R3, Z1, Z2, Ra, Rb, q, A and n are as defined in the description, a pharmaceutically acceptable salt or solvate thereof. The compound is useful as P2X3 and/or P2X2/3 receptor antagonist.

Abstract: The present invention provides novel compounds having a P2X3 and/or P2X2/3 receptor antagonistic effect. A pharmaceutical composition having an analgesic effect or an improving effect of urination disorder comprising a compound of the formula (I): wherein Rh and Rj are taken together to form a bond; Ra and Rb and/or Rd and Re are taken together to form oxo or the like; Rc is hydrogen, substituted or unsubstituted alkyl or the like; Rf is —(CR4aR4b)n—R2; R4a and R4b are hydrogen, substituted or unsubstituted alkyl or the like; R2 is substituted or unsubstituted cycloalkyl or the like; n is an integer of 1 to 4; —Rg is —X—R3; —X— is —O—, —S— or the like; R3 is substituted or unsubstituted cycloalkyl or the like, or its pharmaceutically acceptable salt or a solvate thereof.

Abstract: A finger authentication device includes a base and an upper case which inclines to a proximal end side with respect to the base, which are integrally formed. The base includes a finger guide on which a finger is set, an optical system for guiding transmissive light penetrating the finger, and an image pick-up unit for picking up a pattern of the light guided by the optical system. Three LEDs each for irradiating the light to the finger set on the finger guide are arranged in the upper case. The light from the LEDs irradiates a center tip and both sides of the finger, respectively.

Abstract: The present invention provides a compound represented by the formula (I): wherein R1, R2, R3, Z1, Z2, Ra, Rb, q, A and n are as defined in the description, a pharmaceutically acceptable salt or solvate thereof. The compound is useful as P2X3 and/or P2X2/3 receptor antagonist.

Abstract: The present invention provides a compound represented by the formula (I): wherein R1, R2, R3, Z1, Z2, Ra, Rb, q, A and n are as defined in the description, a pharmaceutically acceptable salt or solvate thereof. The compound is useful as P2X3 and/or P2X2/3 receptor antagonist.

Abstract: The present invention provides a novel P2X3 and/or P2X2/3 receptor antagonist. A compound represented by the formula (I); wherein Ra, Rb and Rc are, (a) Ra and Rb are taken together ?Z; and Rc is a group represented by R1c; or (b) Rb and Rc are taken together to form a bond; and Ra is a group represented by —Y—R1a; R1a and R1c are each independently hydrogen, substituted or unsubstituted alkyl, etc.; R2 and R3 are each independently substituted or unsubstituted aryl, etc.; R4a and R4b are each independently hydrogen, substituted or unsubstituted alkyl, etc.; X is —N(R5)—, etc.; R5 is hydrogen, substituted or unsubstituted lower alkyl, etc.; —Y— is —O—, etc.; ?Z is ?O, etc.; and n is an integer of 0 to 4.

Abstract: A finger authentication device includes a base and an upper case which inclines to a proximal end side with respect to the base, which are integrally formed. The base includes a finger guide on which a finger is set, an optical system for guiding transmissive light penetrating the finger, and an image pick-up unit for picking up a pattern of the light guided by the optical system. Three LEDs each for irradiating the light to the finger set on the finger guide are arranged in the upper case. The light from the LEDs irradiates a center tip and both sides of the finger, respectively.

Abstract: The present invention provides a compound represented by the formula (I): wherein R1, R2, R3, Z1, Z2, Ra, Rb, q, A and n are as defined in the description, a pharmaceutically acceptable salt or solvate thereof. The compound is useful as P2X3 and/or P2X2/3 receptor antagonist.

Abstract: The current position of a work is sequentially updated in a conveyor coordinate system, and the path of a robot to follow the work is formed by transforming the position of the work from the conveyor coordinate system to a robot coordinate system.

Abstract: The current position of a work is sequentially updated in a conveyor coordinate system, and the path of a robot to follow the work is formed by transforming the position of the work from the conveyor coordinate system to a robot coordinate system.